Early Detection, Timely Action
Early identification of emerging safety signals enables prompt assessment and appropriate corrective measures, helping reduce patient risk.
Smarter Signal Detection. Stronger Risk Control.
Detect Early. Act Smarter. Stay Compliant.
Effective signal detection requires continuous monitoring, clinical expertise, and a structured approach to risk evaluation. Potential safety signals are identified early, carefully assessed, and documented in accordance with global regulatory requirements, enabling informed decision-making and maintaining a balanced benefit–risk profile.
- Continuous safety data monitoring across regulatory authority portals, spontaneous reports, literature, and other relevant sources
- Early identification of potential safety risks to support timely and evidence-based interventions
- Structured signal management workflow with integrated tracking systems for complete visibility and control
- Support for regulatory decision-making and reporting obligations in line with global pharmacovigilance requirements
Excellence in Signal Management
Detect Early. Act with Confidence.
Real-Time Safety Oversight and trends
|
Automated alerts with causality category
|
40
Faster Signal Detection with AI Support
|
Structured Signal Workflow Management and Tracking
|
Inspection-Ready PV Systems
Key Capabilities in Signal Management
Smarter Signal Management for Faster Safety Decisions
Our capabilities leverage AI to strengthen signal detection, structured assessment, and seamless communication across the pharmacovigilance workflow, ensuring efficiency and compliance.
-
Continuous safety database monitoring
-
Quantitative statistical signal detection (PRR and Chi-square)
-
AutoAlerts (IME, DME, and special population) and Monitored events review
-
Qualitative clinical assessment by a safety physician
-
AI-driven literature surveillance for signal
-
Integrated Signal management workflow and tracking tool
-
Safety variation notification workflow to the regulatory affairs team
Proactive Risk Mitigation & Safety Communication
Smarter Risk Insights for Faster Safety Action
Benefit–Risk Optimization
Combines clinical evaluation of signals and alerts with data-driven insights to maintain a balanced benefit–risk profile throughout the product lifecycle.
Cross-Functional Coordination
Ensures effective collaboration between safety physicians, pharmacovigilance experts, and regulatory teams to support informed and timely decision-making.
Signal Management Workflow
Structured Steps. Smarter Outcomes.
How Sciom Delivers:
- Data Aggregation:Integration of internal and external databases, including EVDAS and FAERS, into a unified safety signal dashboard for comprehensive data visibility
- Signal Detection: AI-assisted quantitative and qualitative analysis to identify emerging safety risks, incorporating Signal of Disproportionate Reporting (SDR), auto-alerts, and monitored events review
- Expert Review: Clinical evaluation by safety physicians to assess signal relevance and potential patient impact
- Risk Mitigation Planning: Updates to core safety documents, including RMPs, REMS, and internal safety protocols based on signal assessment outcomes
- Regulatory Communication: Preparation of safety reports, regulatory notifications, and committee-ready documentation
- Continuous Monitoring: Ongoing surveillance to ensure early identification of new and evolving safety signals
Why Sciom for Signal Management
Where Insight Meets Precision
- Experienced QPPVs, safety physicians, and pharmacovigilance experts with deep therapeutic area knowledge
- AI-supported signal analytics enabling faster and more accurate detection compared to traditional approaches
- Structured signal management workflows with integrated tracking and scheduling tools for complete oversight
- Inspection-ready pharmacovigilance governance supported by well-documented and compliant processes
- Tailored, product-specific safety strategies aligned with regulatory expectations and lifecycle requirements
Insights & Industry Trends
Stay informed with expert commentary on pharmacovigilance services, regulatory consulting services, analytical science and audit compliance services across the pharmaceutical industry.
